(Post-pandemic Era)-Global The CRISPR And CRISPR-Associated (Cas) Genes Market Segment Research Report 2023

Report ID: 874676 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The CRISPR And CRISPR-Associated (Cas) Genes Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The CRISPR And CRISPR-Associated (Cas) Genes Market by Value
      2.2.1 Global The CRISPR And CRISPR-Associated (Cas) Genes Revenue by Type
      2.2.2 Global The CRISPR And CRISPR-Associated (Cas) Genes Market by Value (%)
    2.3 Global The CRISPR And CRISPR-Associated (Cas) Genes Market by Production
      2.3.1 Global The CRISPR And CRISPR-Associated (Cas) Genes Production by Type
      2.3.2 Global The CRISPR And CRISPR-Associated (Cas) Genes Market by Production (%)

3. The Major Driver of The CRISPR And CRISPR-Associated (Cas) Genes Industry
    3.1 Historical & Forecast Global The CRISPR And CRISPR-Associated (Cas) Genes Demand
    3.2 Largest Application for The CRISPR And CRISPR-Associated (Cas) Genes (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The CRISPR And CRISPR-Associated (Cas) Genes Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The CRISPR And CRISPR-Associated (Cas) Genes Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The CRISPR And CRISPR-Associated (Cas) Genes Average Price Trend
    12.1 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in US (2017-2021)
    12.2 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Europe (2017-2021)
    12.3 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in China (2017-2021)
    12.4 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Japan (2017-2021)
    12.5 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in India (2017-2021)
    12.6 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Korea (2017-2021)
    12.7 Market Price for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The CRISPR And CRISPR-Associated (Cas) Genes

14. The CRISPR And CRISPR-Associated (Cas) Genes Competitive Landscape
     14.1 Caribou Biosciences
        14.1.1 Caribou Biosciences Company Profiles
        14.1.2 Caribou Biosciences Product Introduction
        14.1.3 Caribou Biosciences The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Thermo Fisher Scientific
        14.2.1 Thermo Fisher Scientific Company Profiles
        14.2.2 Thermo Fisher Scientific Product Introduction
        14.2.3 Thermo Fisher Scientific The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Merck KGaA
        14.3.1 Merck KGaA Company Profiles
        14.3.2 Merck KGaA Product Introduction
        14.3.3 Merck KGaA The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Addgene
        14.4.1 Addgene Company Profiles
        14.4.2 Addgene Product Introduction
        14.4.3 Addgene The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Takara Bio USA
        14.5.1 Takara Bio USA Company Profiles
        14.5.2 Takara Bio USA Product Introduction
        14.5.3 Takara Bio USA The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 CRISPR THERAPEUTICS
        14.6.1 CRISPR THERAPEUTICS Company Profiles
        14.6.2 CRISPR THERAPEUTICS Product Introduction
        14.6.3 CRISPR THERAPEUTICS The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Intellia Therapeutics
        14.7.1 Intellia Therapeutics Company Profiles
        14.7.2 Intellia Therapeutics Product Introduction
        14.7.3 Intellia Therapeutics The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Editas Medicine
        14.8.1 Editas Medicine Company Profiles
        14.8.2 Editas Medicine Product Introduction
        14.8.3 Editas Medicine The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Mirus Bio LLC
        14.9.1 Mirus Bio LLC Company Profiles
        14.9.2 Mirus Bio LLC Product Introduction
        14.9.3 Mirus Bio LLC The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Horizon Discovery Group
        14.10.1 Horizon Discovery Group Company Profiles
        14.10.2 Horizon Discovery Group Product Introduction
        14.10.3 Horizon Discovery Group The CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 GE Healthcare Dharmacon
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The CRISPR And CRISPR-Associated (Cas) Genes Industry (Volume)
    Figure 2. The CRISPR And CRISPR-Associated (Cas) Genes Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The CRISPR And CRISPR-Associated (Cas) Genes Revenue in 2021
    Figure 5. US The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The CRISPR And CRISPR-Associated (Cas) Genes Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The CRISPR And CRISPR-Associated (Cas) Genes Revenue, by Type (Million USD) (2017-2027)
    Table 4. The CRISPR And CRISPR-Associated (Cas) Genes Production, by Type (K Unit) (2017-2027)
    Table 5. The CRISPR And CRISPR-Associated (Cas) Genes Demand (K Unit) by Application (2017-2027)
    Table 6. The CRISPR And CRISPR-Associated (Cas) Genes Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The CRISPR And CRISPR-Associated (Cas) Genes Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The CRISPR And CRISPR-Associated (Cas) Genes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The CRISPR And CRISPR-Associated (Cas) Genes in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Caribou Biosciences Profiles
    Table 61. Caribou Biosciences The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 62. Caribou Biosciences The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Caribou Biosciences Strategic initiatives
    Table 64. Thermo Fisher Scientific Profiles
    Table 65. Thermo Fisher Scientific The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 66. Thermo Fisher Scientific The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Thermo Fisher Scientific Strategic initiatives
    Table 68. Merck KGaA Profiles
    Table 69. Merck KGaA The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 70. Merck KGaA The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Merck KGaA Strategic initiatives
    Table 72. Addgene Profiles
    Table 73. Addgene The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 74. Addgene The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Addgene Strategic initiatives
    Table 76. Takara Bio USA Profiles
    Table 77. Takara Bio USA The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 78. Takara Bio USA The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Takara Bio USA Strategic initiatives
    Table 80. CRISPR THERAPEUTICS Profiles
    Table 81. CRISPR THERAPEUTICS The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 82. CRISPR THERAPEUTICS The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. CRISPR THERAPEUTICS Strategic initiatives
    Table 84. Intellia Therapeutics Profiles
    Table 85. Intellia Therapeutics The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 86. Intellia Therapeutics The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Intellia Therapeutics Strategic initiatives
    Table 88. Editas Medicine Profiles
    Table 89. Editas Medicine The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 90. Editas Medicine The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Editas Medicine Strategic initiatives
    Table 92. Mirus Bio LLC Profiles
    Table 93. Mirus Bio LLC The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 94. Mirus Bio LLC The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Mirus Bio LLC Strategic initiatives
    Table 97. Horizon Discovery Group Profiles
    Table 98. Horizon Discovery Group The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 99. Horizon Discovery Group The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Horizon Discovery Group Strategic initiatives
    Table 101. GE Healthcare Dharmacon Profiles
    Table 102. GE Healthcare Dharmacon The CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
    Table 103. GE Healthcare Dharmacon The CRISPR And CRISPR-Associated (Cas) Genes Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The CRISPR And CRISPR-Associated Genes Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The CRISPR And CRISPR-Associated Genes Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The CRISPR And CRISPR-Associated Genes Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports